Cart
sales@molnova.com
Selodenoson
CAS No. 110299-05-3
Selodenoson( —— )
Catalog No. M34419 CAS No. 110299-05-3
Selodenoson (RG-14202) is a selective adenosine A1 receptor agonist used to slow the heart rate in patients with atrial fibrillation and to treat arrhythmias.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 202 | Get Quote |
|
| 5MG | 304 | Get Quote |
|
| 10MG | 447 | Get Quote |
|
| 25MG | 710 | Get Quote |
|
| 50MG | 994 | Get Quote |
|
| 100MG | 1314 | Get Quote |
|
| 500MG | 2628 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSelodenoson
-
NoteResearch use only, not for human use.
-
Brief DescriptionSelodenoson (RG-14202) is a selective adenosine A1 receptor agonist used to slow the heart rate in patients with atrial fibrillation and to treat arrhythmias.
-
DescriptionSelodenoson (RG-14202) is a selective adenosine A1 receptor agonist used to slow the heart rate in patients with atrial fibrillation and to treat arrhythmias.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAdenosine Receptor
-
RecptorAdenosine Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number110299-05-3
-
Formula Weight376.41
-
Molecular FormulaC17H24N6O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO[C@H]1[C@H](N2C=3C(N=C2)=C(NC4CCCC4)N=CN3)O[C@H](C(NCC)=O)[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
YT 146
YT 146 is a selective adenosine receptor A2 agonist with cardioprotective and vasodilatory effects that inhibits neointimal thickening after endothelial injury in rat femoral arteries.
-
2-Cl-IB-MECA
2-Cl-IB-MECA (Chloro-IB-MECA, CF-102, Namodenoson) is a potent, selective A3 adenosine receptor agonist with Ki of 0.33 nM, 2500- and 1400-fold selectivity over A1 and A2a receptors.
-
MRS1220
MRS1220, a selective and potent antagonist for the human A3 adenosine receptor (hA3AR) with a dissociation constant (Ki) of 0.59 nM, exhibits therapeutic promise for central nervous system disease research.
